Senti Biosciences Stock Investor Sentiment

SNTI Stock  USD 4.36  0.34  8.46%   
Under 55% of Senti Biosciences' traders are presently thinking to get in. The analysis of the overall investor sentiment regarding Senti Biosciences suggests that some traders are interested. Senti Biosciences' investing sentiment shows overall attitude of investors towards Senti Biosciences.
  
over a week ago at news.google.com         
Senti Biosciences CEO Timothy Lu sells shares worth 18,338 - MSN
Google News at Macroaxis
over a week ago at thelincolnianonline.com         
Senti Biosciences, Inc. CEO Timothy K. Lu Sells 3,922 Shares
news
over a week ago at www.macroaxis.com         
Disposition of 182 shares by Rajangam Kanya of Senti Biosciences at 4.37 subject to Rule 16b-3
Macroaxis News
over a week ago at www.macroaxis.com         
Disposition of 1297 shares by Rajangam Kanya of Senti Biosciences at 4.07 subject to Rule 16b-3
Macroaxis News
over a month ago at thelincolnianonline.com         
Senti Biosciences, Inc. Short Interest Update
news
over a month ago at finance.yahoo.com         
Senti Bio Announces Additional 11.5 Million of Financing
Yahoo News
over a month ago at seekingalpha.com         
Senti Biosciences receives additional investment of 10M
seekingalpha News
over a month ago at news.google.com         
How Is The Market Feeling About Senti Biosciences - Benzinga
Google News at Macroaxis
over a month ago at www.macroaxis.com         
Acquisition by Rajangam Kanya of 152000 shares of Senti Biosciences at 0.46 subject to Rule 16b-3
Macroaxis News
over two months ago at finance.yahoo.com         
Senti Bio Announces First Patient Dosed in Clinical Trial of SN301A in Hepatocellular Carcinoma in C...
Yahoo News
over two months ago at www.macroaxis.com         
Acquisition by Rajangam Kanya of tradable shares of Senti Biosciences at 2.25 subject to Rule 16b-3
Macroaxis News
over two months ago at www.macroaxis.com         
Acquisition by Rajangam Kanya of tradable shares of Senti Biosciences at 2.25 subject to Rule 16b-3
Macroaxis News
over two months ago at Macroaxis         
Will Senti (USA Stocks:SNTI) continue to grow in January?
Macroaxis News
over two months ago at investing.com         
Chardan lifts Senti Biosciences stock target on positive trial data
Investing News at Macroaxis
over two months ago at kalkinemedia.com         
Senti Biosciences Inc. Announces Employment Inducement Grants for New Employees
news
Far too much social signal, news, headlines, and media speculation about Senti Biosciences that are available to investors today. That information is available publicly through Senti media outlets and privately through word of mouth or via Senti internal channels. However, regardless of the origin, that massive amount of Senti data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Senti Biosciences news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Senti Biosciences relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Senti Biosciences' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Senti Biosciences alpha.

Senti Biosciences Performance against Dow Jones

 Price Growth (%)  
       Timeline  

Complementary Tools for Senti Stock analysis

When running Senti Biosciences' price analysis, check to measure Senti Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Senti Biosciences is operating at the current time. Most of Senti Biosciences' value examination focuses on studying past and present price action to predict the probability of Senti Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Senti Biosciences' price. Additionally, you may evaluate how the addition of Senti Biosciences to your portfolios can decrease your overall portfolio volatility.
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Commodity Directory
Find actively traded commodities issued by global exchanges
Bonds Directory
Find actively traded corporate debentures issued by US companies
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities